期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
CETP as a Target in HDL-raising Therapy:lessons from APOE*3-Leiden. CETP Transgenic Mice 被引量:2
1
作者 Willeke de Haan jitske de Vries-van der Weij +6 位作者 Caroline C. van der Hoogt josé W.A. van der Hoorn johannes A. Romijn j. wouter jukema Louis M. Havekes Hans M.G. Princen Patrick C.N. Rensen 《中国动脉硬化杂志》 CAS CSCD 北大核心 2009年第7期574-575,共2页
Background Cardiovascular disease (CVD) is mainly caused by atherosclerosis,for which dyslipidemia (i.e. high (V)LDL-cholesterol (C),high triglycerides and low HDLC is a major risk factor. To reduce the risk to develo... Background Cardiovascular disease (CVD) is mainly caused by atherosclerosis,for which dyslipidemia (i.e. high (V)LDL-cholesterol (C),high triglycerides and low HDLC is a major risk factor. To reduce the risk to develop CVD,patients with dyslipidemia are usually treated with lipid-lowering drugs including statins and fibrates. 展开更多
关键词 心血管疾病 动脉粥样硬化 血脂 胆固醇 临床分析
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部